國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Novel therapeutics for rare lymphomas

Dittus, Christopher.

Novel therapeutics for rare lymphomas

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Novel therapeutics for rare lymphomasedited by Christopher Dittus.
其他作者:	Dittus, Christopher.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	x, 253 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
標題:	LymphomasTreatment.
電子資源:	https://doi.org/10.1007/978-3-030-25610-4
ISBN:	9783030256104$q(electronic bk.)

Novel therapeutics for rare lymphomas
Novel therapeutics for rare lymphomas[electronic resource] /edited by Christopher Dittus. - Cham :Springer International Publishing :2020. - x, 253 p. :ill. (some col.), digital ;24 cm.

The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

ISBN: 9783030256104$q(electronic bk.)

Standard No.: 10.1007/978-3-030-25610-4doiSubjects--Topical Terms:

520176
Lymphomas
--Treatment.

LC Class. No.: RC280.L9

Dewey Class. No.: 616.99446

Novel therapeutics for rare lymphomas
LDR:02457nmm a2200325 a 4500 001 576832
003 DE-He213
005 20200304115441.0
006 m d
007 cr nn 008maaau
008 201120s2020 gw s 0 eng d
020 $a 9783030256104$q(electronic bk.)
020 $a 9783030256098$q(paper)
024 7 $a 10.1007/978-3-030-25610-4 $2 doi
035 $a 978-3-030-25610-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.L9
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99446 $2 23
090 $a RC280.L9 $b N937 2020
245 0 0 $a Novel therapeutics for rare lymphomas $h [electronic resource] / $c edited by Christopher Dittus.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a x, 253 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a The Hematopathology and Diagnostic Challenges of Rare Lymphomas -- Novel Therapeutics in the Management of Waldenstrom Macroglobulinemia -- Immunotherapy in Hodgkin Lymphoma and other CD30+ Lymphomas -- Chronic Lymphocytic Leukemia with Alterations in TP53 -- Mantel Cell Lymphoma -- Current and Emerging Treatment Strategies from Primary Mediastinal B-Cell Lymphoma -- Plasmablastic Lymphoma and Primary Effusion Lymphoma -- Novel Agents in Primary Central Nervous System Lymphoma -- Adult T-Cell Leukemia/Lymphoma -- Extranodal NK/T-Cell Lymphoma -- Anaplastic Large Cell Lymphoma -- Enteropathy-Associated T-Cell Lymphomas -- Hepatosplenic T-Cell Lymphoma -- Cutaneous T-Cell Lymphoma: Mycosis Fungoides and Sezary Syndrom.
520 $a This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.
650 0 $a Lymphomas $x Treatment. $3 520176
650 1 4 $a Oncology. $3 195181
650 2 4 $a Hematology. $3 274899
700 1 $a Dittus, Christopher. $3 864984
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-25610-4
950 $a Medicine (Springer-11650)